Dual–time point 18F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations
dc.contributor.author | Parghane, R. V. | |
dc.contributor.author | Basu, Sandip | |
dc.date.accessioned | 2020-11-04T05:09:47Z | |
dc.date.available | 2020-11-04T05:09:47Z | |
dc.date.issued | 2017 | |
dc.description.division | RMC | en |
dc.format.extent | 6151 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Seminars in Nuclear Medicine, 2017. Vol. 47 (4): pp. 373-391 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/21163 | |
dc.language.iso | en | en |
dc.subject | Dual-time point 18F-FDG-PET and PET/CT | en |
dc.subject | Malignant Musculoskeletal Lesions | en |
dc.subject | Opportunities and Limitations | en |
dc.subject | clinical applications | en |
dc.title | Dual–time point 18F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations | en |
dc.type | Article | en |